These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12728544)

  • 1. [Current status of nuclear neuroimaging].
    Kuwabara Y
    Fukuoka Igaku Zasshi; 2003 Feb; 94(2):26-30. PubMed ID: 12728544
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine.
    Vander Borght T; Laloux P; Maes A; Salmon E; Goethals I; Goldman S;
    Acta Neurol Belg; 2001 Dec; 101(4):196-209. PubMed ID: 11851026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for brain perfusion SPECT with technetium-99m radiopharmaceuticals].
    Menzel C
    Nuklearmedizin; 1999; 38(6A):237-9. PubMed ID: 10510817
    [No Abstract]   [Full Text] [Related]  

  • 4. Procedure guideline for brain perfusion SPECT using technetium-99m radiopharmaceuticals. Society of Nuclear Medicine.
    Juni JE; Waxman AD; Devous MD; Tikofsky RS; Ichise M; Van Heertum RL; Holman BL; Carretta RF; Chen CC
    J Nucl Med; 1998 May; 39(5):923-6. PubMed ID: 9591602
    [No Abstract]   [Full Text] [Related]  

  • 5. The use and applications of single-photon emission computerised tomography in dementia.
    Geaney DP; Abou-Saleh MT
    Br J Psychiatry Suppl; 1990; (9):66-75. PubMed ID: 2291821
    [No Abstract]   [Full Text] [Related]  

  • 6. Is brain SPECT useful in degenerative dementia diagnosis?
    Farid K; Caillat-Vigneron N; Sibon I
    J Comput Assist Tomogr; 2011; 35(1):1-3. PubMed ID: 21160432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain spect perfusion of frontotemporal dementia associated with motor neuron disease.
    Guedj E; Le Ber I; Lacomblez L; Dubois B; Verpillat P; Didic M; Salachas F; Vera P; Hannequin D; Lotterie JA; Puel M; Decousus M; Thomas-Antérion C; Magne C; Vercelletto M; Bernard AM; Golfier V; Pasquier J; Michel BF; Namer I; Sellal F; Bochet J; Volteau M; Brice A; Meininger V; ; Habert MO
    Neurology; 2007 Jul; 69(5):488-90. PubMed ID: 17664410
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional brain imaging with cerebral perfusion SPECT in cerebrovascular disease, epilepsy, and trauma.
    Lewis DH
    Neurosurg Clin N Am; 1997 Jul; 8(3):337-44. PubMed ID: 9188542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain glucose metabolism in Parkinson's disease.
    Metter EJ; Kuhl DE; Riege WH
    Adv Neurol; 1990; 53():135-9. PubMed ID: 2239454
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease.
    Baron JC; Frackowiak RS; Herholz K; Jones T; Lammertsma AA; Mazoyer B; Wienhard K
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):723-42. PubMed ID: 2684991
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 12. Parkinson's disease: positron emission tomographic studies.
    Martin WR
    Semin Neurol; 1989 Dec; 9(4):345-50. PubMed ID: 2701779
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the drawbacks of single photon emission computed tomography and positron emission tomography imaging].
    Mizumura S
    Brain Nerve; 2010 May; 62(5):489-500. PubMed ID: 20450096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TechSight. Imaging. A molecular map for neurodegeneration.
    Marek K; Seibyl J
    Science; 2000 Jul; 289(5478):409-11. PubMed ID: 10939953
    [No Abstract]   [Full Text] [Related]  

  • 15. Single photon emission computed tomography in Alzheimer's disease and related disorders.
    Newberg AB; Alavi A; Payer F
    Neuroimaging Clin N Am; 1995 Feb; 5(1):103-23. PubMed ID: 7743079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter imaging.
    Lees AJ; Grosset DG
    Mov Disord; 2003 Oct; 18 Suppl 7():S1-2. PubMed ID: 14531038
    [No Abstract]   [Full Text] [Related]  

  • 17. Functional brain imaging in late-life depression and dementia.
    Kumar A
    J Clin Psychiatry; 1993 Nov; 54 Suppl():21-5. PubMed ID: 8270594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling reality with emission tomography: what is the point?
    Link JM
    J Nucl Med; 1996 Jul; 37(7):1241. PubMed ID: 8965205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Functional neuroimaging in movement disorders].
    Borbély K
    Orv Hetil; 2001 Oct; 142(43):2347-55. PubMed ID: 11760452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of imaging in prion disease.
    Taber KH; Cortelli P; Staffen W; Hurley RA
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):371-6. PubMed ID: 12426406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.